Tempus Labs, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. Tempus has one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful. It is headquartered in Chicago, Illinois, United States. Tempus has raised $1.3B in funding.
Tempus uses AI to gather and analyze massive pools of medical and clinical data at scale. The company, with the assistance of AI, provides precision medicine that personalizes and optimizes treatments to each individual’s specific health needs, relying on everything from genetic makeup to past medical history to diagnose and treat. Tempus, specializing in “data-driven precision medicine,” uses an AI application strategy to fight disease and bolster patient outcomes. It gathers and analyzes massive pools of medical and clinical data at scale to provide precision medicine that personalizes and optimizes treatments to each individual’s specific health needs. Applications include neurology, psychiatry, and oncology.